American science and technology incubator, accelerator, and seed-stage venture capital firm Innosphere has announced its 2026 Life Sciences Incubator cohort, featuring 38 startups developing next-generation technologies across digital health, medical devices, diagnostics, therapeutics and broader life sciences sectors. The program is supported by the U.S. Economic Development Administration through its Build to Scale Grant initiative.
The 2026 cohort highlights growing momentum in healthcare innovation, particularly in AI-powered clinical technologies, advanced diagnostics, connected medical devices and data-driven patient care solutions. Participating companies are developing technologies ranging from wearable monitoring systems and point-of-care diagnostic platforms to predictive analytics tools designed to improve clinical decision-making and patient outcomes.
The selected startups represent emerging innovation areas including biomedical sciences, artificial intelligence and machine learning, neurotechnology, nanotechnology, regenerative medicine and advanced medical device engineering. Several companies are focused on addressing challenges in early disease detection, personalized treatment pathways and healthcare accessibility through scalable digital solutions.
Innosphere said the 2026 cohort includes startups from nine U.S. states and two international markets, with strong representation from Colorado, Utah, South Carolina and Nebraska. Many of the ventures are spinouts or research-driven companies originating from leading academic institutions including the University of Utah, Medical University of South Carolina, University of Nebraska, Colorado State University and the University of Colorado.
The incubator program provides participating companies with strategic mentorship, commercialization guidance, investor access and operational support aimed at accelerating lab-to-market healthcare innovation. The program will conclude with a national showcase event scheduled for December 2026.
The organization said the previous 2025 cohort included 31 life sciences startups that collectively filed 27 patents, secured more than $24.1 million in funding and created 45 jobs with an average salary of $89,000. Innosphere added that nearly half of those companies established strategic partnerships during the program.
The initiative builds on Innosphere’s earlier Colorado-focused life sciences incubation efforts developed in collaboration with the Colorado BioScience Association and supported by the Colorado Office of Economic Development and International Trade.
“This cohort reflects where life sciences innovation is heading — not only scientifically, but commercially,” said an Innosphere spokesperson. “We are seeing founders combine deep technical expertise with strong market awareness, particularly in digital health and medical technologies. Our focus is helping these companies connect with capital, strategic partners and commercialization opportunities that can accelerate meaningful healthcare impact.”
